SCHEMBL22964159

SCHEMBL22964159

Oc1cccc(OCc2ccccn2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 1/20 0.53
TLR2 O60603 1/20 0.53
PARP10 Q53GL7 1/20 0.53
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KCNH2 Q12809 1/20 0.50
APP P05067 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
GPR132 Q9UNW8 1/20 0.49
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
DRD2 P14416 2/20 0.46
ABCB1 P08183 1/20 0.46
HTR1A P08908 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090065 0.85 CHRNB2 (0.50) TLR4TLR2ALDH1A1KDM4EAPP
SCHEMBL9384981 0.82 GPBAR1 (0.62) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL2649525 0.81 MAOB (0.60) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL22597086 0.81 TLR4 (0.52) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL29468767 0.81 MAOB (0.60) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL9719812 0.81 MAOB (0.60) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL13645800 0.81 KDM4E (0.55) TLR4TLR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL791890 0.81 FFAR1 (0.61) TLR4TLR2APPDRD2ABCB1
SCHEMBL6445371 0.81 KCNH2 (0.67) TLR4TLR2PARP10ALDH1A1KDM4E
SCHEMBL13008164 0.81 POLB (0.53) TLR4TLR2PARP10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961231-B2 NTCP inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-03-30 US disclosed
US-20210040072-A1 NTCP Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-02-11 US disclosed
CN-107344940-B BTK inhibitors and uses thereof 广东东阳光药业有限公司 2020-04-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040072-A1 NTCP Inhibitors HAVCR2, NPC1, HMGCR TLR4 2154/4885TLR2 2632/4885PARP10 2783/4885
US-10961231-B2 NTCP inhibitors HAVCR2, NPC1, HMGCR TLR4 2154/4885TLR2 2632/4885PARP10 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.